Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 41 Total
SLNG - Stabilis Solutions Inc - Stock Price Chart
TickerSLNG [NASD]
CompanyStabilis Solutions Inc
CountryUSA
IndustryOil & Gas Integrated
Market Cap73.62MEPS (ttm)0.03
P/E148.31EPS this Y3300.00%
Forward P/E11.31EPS next Y2.94%
PEG-EPS past 5Y-
P/S1.11EPS next 5Y-
P/B1.16EPS Q/Q35.21%
Dividend-Sales Q/Q-26.35%
Insider Own88.41%Inst Own3.67%
Insider Trans0.03%Inst Trans20.27%
Short Float0.19%EarningsMay 07/a
Analyst Recom1.00Target Price9.00
Avg Volume4.46K52W Range3.85 - 6.40
May-09-24 07:01PM Stabilis Solutions Inc (SLNG) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and ... (GuruFocus.com)
May-07-24 04:25PM Stabilis Solutions Announces Strong First Quarter 2024 Results (ACCESSWIRE)
Apr-30-24 08:30AM Stabilis Solutions Announces Extension of LNG Fuel Contract in Support of Grid Resiliency (ACCESSWIRE)
Apr-24-24 08:30AM Stabilis Solutions Announces First Quarter 2024 Conference Call and Webcast Date (ACCESSWIRE)
Apr-03-24 08:30AM Stabilis Solutions To Become Major Supplier of High-Purity Rocket Propellant to Commercial Space Industry (ACCESSWIRE)
Mar-08-24 08:38AM Stabilis Solutions, Inc. (NASDAQ:SLNG) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 10:51PM SLNG Stock Earnings: Stabilis Solutions Reported Results for Q4 2023 (InvestorPlace) +11.69% -10.47%
05:05PM Stabilis Solutions Announces Fourth Quarter and Full Year 2023 Results (ACCESSWIRE)
Feb-22-24 08:00AM Stabilis Solutions Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast Date (ACCESSWIRE)
Nov-14-23 08:55AM Sidoti Events, LLCs Virtual November Micro-Cap Conference (ACCESSWIRE)
CVR - Chicago Rivet & Machine Co. - Stock Price Chart
TickerCVR [AMEX]
CompanyChicago Rivet & Machine Co.
CountryUSA
IndustryTools & Accessories
Market Cap15.04MEPS (ttm)-4.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.49EPS next 5Y-
P/B0.59EPS Q/Q-19.70%
Dividend2.58%Sales Q/Q-10.04%
Insider Own23.60%Inst Own18.72%
Insider Trans0.00%Inst Trans-1.37%
Short Float0.58%Earnings-
Analyst Recom-Target Price-
Avg Volume1.96K52W Range14.73 - 28.00
May-14-24 02:35PM CHICAGO RIVET & MACHINE CO. DECLARES DIVIDEND (PR Newswire)
May-10-24 04:45PM Chicago Rivet & Machine Co. Announces First Quarter Results of Operations (PR Newswire)
Mar-28-24 04:45PM Chicago Rivet & Machine Co. Announces Year-End Results of Operations (PR Newswire)
Feb-19-24 01:41PM CHICAGO RIVET & MACHINE CO. DECLARES DIVIDEND (PR Newswire)
Nov-20-23 01:44PM CHICAGO RIVET & MACHINE CO. DECLARES DIVIDEND (PR Newswire)
Nov-07-23 04:45PM Chicago Rivet & Machine Co. Announces Third Quarter Results of Operations (PR Newswire)
Aug-21-23 06:25PM CHICAGO RIVET & MACHINE CO. DECLARES DIVIDEND (PR Newswire)
Aug-07-23 05:00PM Chicago Rivet & Machine Co. Announces Second Quarter Results of Operations (PR Newswire) -5.51%
May-09-23 03:14PM CHICAGO RIVET & MACHINE CO. DECLARES DIVIDEND (PR Newswire)
May-08-23 05:00PM Chicago Rivet & Machine Co. Announces First Quarter Results of Operations (PR Newswire)
MNOV - Medicinova Inc - Stock Price Chart
TickerMNOV [NASD]
CompanyMedicinova Inc
CountryUSA
IndustryBiotechnology
Market Cap64.26MEPS (ttm)-0.17
P/E-EPS this Y-35.29%
Forward P/E-EPS next Y-4.35%
PEG-EPS past 5Y13.30%
P/S64.26EPS next 5Y20.00%
P/B1.07EPS Q/Q5.55%
Dividend-Sales Q/Q-
Insider Own5.24%Inst Own18.55%
Insider Trans0.00%Inst Trans-0.93%
Short Float0.29%EarningsMay 10/b
Analyst Recom1.00Target Price16.50
Avg Volume30.09K52W Range1.26 - 2.66
Jun-05-24 06:00AM MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Various Solid Cancer (GlobeNewswire)
Jun-03-24 06:00AM MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Patients at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024 (GlobeNewswire) +8.09%
May-28-24 06:00AM MediciNova Announces Two Poster Presentations at the 92nd EAS Congress 2024, the Annual Meeting of the European Atherosclerosis Society Regarding the Use of MN-001 (Tipelukast) for Cardiometabolic Conditions (GlobeNewswire)
May-20-24 06:00AM MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer (GlobeNewswire)
May-14-24 06:00AM MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Chlorine-Induced Acute Respiratory Distress Syndrome (GlobeNewswire)
May-10-24 08:52AM MNOV Stock Earnings: MediciNova Misses EPS for Q1 2024 (InvestorPlace)
May-09-24 07:45PM MediciNova: Q1 Earnings Snapshot (Associated Press Finance) +8.15%
May-07-24 06:00AM MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast) (GlobeNewswire)
Apr-02-24 07:00PM MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO) (GlobeNewswire)
Mar-26-24 07:00PM MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan (GlobeNewswire) +8.09%
USGO - U.S. GoldMining Inc - Stock Price Chart
TickerUSGO [NASD]
CompanyU.S. GoldMining Inc
CountryCanada
IndustryOther Industrial Metals & Mining
Market Cap74.40MEPS (ttm)-0.76
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B6.69EPS Q/Q-6.45%
Dividend-Sales Q/Q-
Insider Own89.07%Inst Own4.21%
Insider Trans0.00%Inst Trans-
Short Float0.07%Earnings-
Analyst Recom1.00Target Price23.50
Avg Volume9.59K52W Range4.91 - 13.98
Jun-18-24 06:30AM GoldMining Intersects 37 Metres Grading 2.26 g/t Gold Within Mineralized Corridor of 163 Metres Grading 1.02 g/t Gold at the So Jorge Project, Brazil (PR Newswire)
May-30-24 06:30AM U.S. GoldMining Releases 2024 Sustainability Factsheet (PR Newswire)
May-29-24 06:30AM GOLDMINING COMMENCES DRILLING AT THE SÃO JORGE GOLD PROJECT, BRAZIL (PR Newswire)
06:30AM GOLDMINING COMMENCES DRILLING AT THE SAO JORGE GOLD PROJECT, BRAZIL (PR Newswire)
May-22-24 06:00AM U.S. GoldMining Announces 2024 Exploration Program (PR Newswire) +8.15%
May-16-24 08:22PM GoldMining Announces Voting Results (PR Newswire)
May-02-24 06:30AM GoldMining Releases 2023 Sustainability Report (PR Newswire)
Apr-29-24 06:30AM GoldMining Enhances Value of the Crucero Gold Project, Peru by Reducing Third-Party Royalty (PR Newswire)
Feb-27-24 06:12PM GoldMining Announces Filing of Financial Statements, MD&A, Annual Information Form and Annual Report on Form 40-F (PR Newswire) +6.02% -6.04%
Jan-24-24 06:30AM GoldMining Subsidiary, U.S. GoldMining, Announces Confirmatory Results, Including Highest Drill Intercept to Date at the Whistler Gold-Copper Project, Alaska (PR Newswire)
NKGN - NKGen Biotech Inc - Stock Price Chart
TickerNKGN [NASD]
CompanyNKGen Biotech Inc
CountryUSA
IndustryBiotechnology
Market Cap29.62MEPS (ttm)-4.37
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1486.44%
Dividend-Sales Q/Q-
Insider Own52.88%Inst Own9.71%
Insider Trans0.00%Inst Trans12.77%
Short Float5.12%Earnings-
Analyst Recom-Target Price-
Avg Volume1.93M52W Range0.78 - 12.88
Jun-12-24 01:05PM NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 (GlobeNewswire) -8.51%
Jun-03-24 08:05AM NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 (GlobeNewswire) -6.59%
May-23-24 05:05PM NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -23.66%
May-21-24 09:53AM NKGN Stock Earnings: NKGen Biotech Reported Results for Q1 2024 (InvestorPlace)
May-20-24 11:41AM NKGN Stock Alert: The Alzheimer's News That Has NKGen Biotech Soaring Today (InvestorPlace) +52.68%
08:05AM NKGen Biotech's SNK01 NK Cell Therapy Cleared to Start Phase 2 Clinical Trial in Alzheimer's Disease (GlobeNewswire)
May-16-24 08:05AM NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition (GlobeNewswire)
Apr-29-24 08:00AM NKGen Biotech Announces FDA Clearance of Investigational New Drug (IND) Application for SNK01 NK Cell Therapy in Parkinsons Disease (GlobeNewswire)
Apr-25-24 04:05PM NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer's & Parkinson's Drug Development Summit (GlobeNewswire) +15.79% -18.69%
Apr-24-24 04:45PM NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire) -7.57%
ARGX - Argen X SE ADR - Stock Price Chart
TickerARGX [NASD]
CompanyArgen X SE ADR
CountryNetherlands
IndustryBiotechnology
Market Cap22.46BEPS (ttm)-5.17
P/E-EPS this Y50.10%
Forward P/E125.48EPS next Y216.99%
PEG-EPS past 5Y-17.05%
P/S18.29EPS next 5Y64.60%
P/B5.46EPS Q/Q10.02%
Dividend-Sales Q/Q82.26%
Insider Own0.71%Inst Own56.75%
Insider Trans0.00%Inst Trans-7.14%
Short Float2.18%EarningsMay 09/b
Analyst Recom1.61Target Price467.52
Avg Volume263.99K52W Range327.73 - 550.76
Jun-17-24 01:00AM argenx to unveil its 'Vision 2030: Taking Breakthrough Science to 50,000 Patients' during its Upcoming R&D Day on July 16, 2024 (GlobeNewswire)
Jun-06-24 06:37PM Analyst Report: argenx SE (Morningstar Research)
Jun-04-24 01:00AM argenx to Present at Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
May-30-24 04:02PM After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay (Investor's Business Daily)
May-29-24 04:06PM Biohaven Tumbles After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump (Investor's Business Daily)
10:17AM Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump (Investor's Business Daily)
May-14-24 06:43PM Analyst Report: argenx SE (Morningstar Research) +5.88%
May-13-24 10:30AM JPMorgan Cuts Price Target on Argenx to $500 From $560, Maintains Overweight Rating (MT Newswires)
May-10-24 04:25PM argenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 12:28PM Analyst Report: argenx SE (Morningstar Research)
ALB - Albemarle Corp. - Stock Price Chart
TickerALB [NYSE, S&P 500]
CompanyAlbemarle Corp.
CountryUSA
IndustrySpecialty Chemicals
Market Cap11.70BEPS (ttm)2.75
P/E36.24EPS this Y-85.50%
Forward P/E14.03EPS next Y119.94%
PEG2.41EPS past 5Y16.09%
P/S1.39EPS next 5Y15.02%
P/B1.26EPS Q/Q-100.74%
Dividend1.60%Sales Q/Q-47.26%
Insider Own0.43%Inst Own95.40%
Insider Trans-0.46%Inst Trans1.71%
Short Float13.62%EarningsMay 01/a
Analyst Recom2.10Target Price145.22
Avg Volume2.51M52W Range98.95 - 247.44
Jun-18-24 05:50PM 1 Wall Street Analyst Thinks Albemarle Stock Is Going to $124. Is It a Buy? (Motley Fool)
06:40AM Wall Street Favorites: 3 Battery Stocks With Strong Buy Ratings for June 2024 (InvestorPlace)
06:15AM Rag to Riches: 3 EV Stocks That Could Make Early Investors Rich (InvestorPlace)
Jun-17-24 05:51PM 3 Lithium Stocks to Buy Now: June 2024 (InvestorPlace)
Jun-12-24 09:43PM The 3 Best Lithium Stocks to Buy in June 2024 (InvestorPlace)
04:15PM All the Elements for a Better World: Albemarle Publishes 2023 Sustainability Report (PR Newswire)
Jun-11-24 09:00AM Albemarle Corporation (ALB) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
06:50AM Albemarle Introduces Project Plan for the Kings Mountain Mine to Community (PR Newswire)
Jun-10-24 12:27PM The 3 Best Battery Stocks to Buy in June 2024 (InvestorPlace)
06:15AM The 3 Most Undervalued Lithium Stocks to Buy in June 2024 (InvestorPlace)
PRQR - ProQR Therapeutics N.V - Stock Price Chart
TickerPRQR [NASD]
CompanyProQR Therapeutics N.V
CountryNetherlands
IndustryBiotechnology
Market Cap135.96MEPS (ttm)-0.36
P/E-EPS this Y-24.68%
Forward P/E-EPS next Y-14.57%
PEG-EPS past 5Y21.74%
P/S12.18EPS next 5Y-
P/B3.62EPS Q/Q14.01%
Dividend-Sales Q/Q587.25%
Insider Own35.42%Inst Own22.22%
Insider Trans0.00%Inst Trans-2.73%
Short Float0.46%EarningsMay 09/b
Analyst Recom1.43Target Price4.24
Avg Volume127.74K52W Range1.11 - 3.29
Jun-18-24 08:00AM ProQR Announces Presentation on its Axiomer RNA Editing Technology at RNA Editing Summit (GlobeNewswire)
May-09-24 07:00AM ProQR Announces First Quarter 2024 Operating and Financial Results (GlobeNewswire)
May-08-24 08:00AM ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer RNA Editing Program Targeting NTCP for Cholestatic Diseases (GlobeNewswire)
Apr-23-24 07:00AM ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 (GlobeNewswire)
Apr-22-24 04:31PM ProQR Highlights Upcoming Presentations on Axiomer RNA Editing at ASGCT 27th Annual Meeting (GlobeNewswire)
Apr-19-24 07:00AM ProQR Achieves Successful Defense of New Challenge to its Axiomer IP Portfolio (GlobeNewswire) +6.99%
Mar-13-24 07:00AM ProQR Announces Year End 2023 Operating and Financial Results (GlobeNewswire) +13.66%
Feb-15-24 07:00AM ProQR Announces Japanese Axiomer Patent Upheld Following Opposition Against Its Leading IP Estate for ADAR-mediated RNA Editing (GlobeNewswire)
Jan-19-24 07:00AM ProQR Highlights New Platform Data from Presentation on Axiomer RNA Editing Technology at Deaminet 2024 (GlobeNewswire)
Jan-05-24 07:00AM ProQR and Rett Syndrome Research Trust Join Forces with Axiomer RNA Editing Collaboration (GlobeNewswire)
AEHL - Antelope Enterprise Holdings Ltd - Stock Price Chart
TickerAEHL [NASD]
CompanyAntelope Enterprise Holdings Ltd
CountryChina
IndustryBuilding Products & Equipment
Market Cap17.82MEPS (ttm)-3.79
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y57.87%
P/S0.25EPS next 5Y-
P/B0.48EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own54.30%Inst Own0.29%
Insider Trans0.00%Inst Trans161.85%
Short Float3.11%EarningsMay 07/b
Analyst Recom-Target Price-
Avg Volume272.36K52W Range1.22 - 9.40
May-10-24 07:00AM Antelope Enterprise Announces Second Half and Full Year 2023 Financial Results (GlobeNewswire)
May-09-24 08:30AM Antelope Enterprise Announces Second Half and Fiscal Year End 2023 Earnings Conference Call (GlobeNewswire)
May-07-24 07:00AM Antelope Enterprise Announces Rescheduling of its Second Half and Fiscal Year End 2023 Earnings Conference Call (GlobeNewswire)
May-06-24 08:30AM Antelope Enterprise Schedules Second Half and Fiscal Year End 2023 Earnings Conference Call (GlobeNewswire)
Apr-29-24 09:00AM Antelope Enterprise Announces its Plan to Launch Energy Transmission Business and Appoints Management Team to Spearhead Such Initiative (GlobeNewswire)
Apr-01-24 08:30AM Antelope Enterprise Announces Preliminary Full Year 2023 Revenue of $70.4 Million, a Projected 65% Year-Over-Year Increase (GlobeNewswire) +5.81%
Feb-26-24 09:00AM Antelope Enterprise Announces Closing of $1.3 Million Registered Direct Offering and Private Placement (PR Newswire) -19.87%
Feb-21-24 04:15PM Antelope Enterprise Announces Warrant Exchange Agreements (PR Newswire)
Dec-01-23 08:00AM Antelope Enterprise Announces Changes to its Board of Directors (PR Newswire) +5.33%
Oct-04-23 09:30AM Antelope Enterprise Holdings Regains Compliance with NASDAQ Minimum Bid Price Requirement (PR Newswire)
FBIZ - First Business Financial Services Inc - Stock Price Chart
TickerFBIZ [NASD, RUT]
CompanyFirst Business Financial Services Inc
CountryUSA
IndustryBanks - Regional
Market Cap282.27MEPS (ttm)4.36
P/E7.80EPS this Y4.53%
Forward P/E6.57EPS next Y14.49%
PEG0.98EPS past 5Y18.43%
P/S1.18EPS next 5Y8.00%
P/B0.99EPS Q/Q-0.98%
Dividend2.94%Sales Q/Q23.91%
Insider Own12.64%Inst Own57.40%
Insider Trans-0.09%Inst Trans-1.68%
Short Float0.26%EarningsApr 25/a
Analyst Recom1.60Target Price42.80
Avg Volume11.86K52W Range28.35 - 41.03
Apr-30-24 04:30PM First Business Bank Announces $5.0 Million Share Repurchase Program (Business Wire) +5.11%
Apr-29-24 09:00AM First Business Bank Declares Quarterly Cash Dividends (Business Wire)
Apr-26-24 02:00PM First Business Financial Services Shares Fall After Q1 Earnings Drop, Revenue Rises (MT Newswires)
Apr-25-24 09:53PM FBIZ Stock Earnings: First Business Finl Servs Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:30PM First Business Financial Services (FBIZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:15PM First Business Financial Services (FBIZ) Q1 Earnings and Revenues Miss Estimates (Zacks)
06:03PM First Business Financial Services Inc. Reports Mixed Q1 Results, Misses EPS Estimates (GuruFocus.com)
05:10PM First Business Financial Services: Q1 Earnings Snapshot (Associated Press Finance)
04:30PM First Business Bank Reports First Quarter 2024 Net Income of $8.6 Million (Business Wire)
Apr-18-24 10:01AM First Business Financial Services (FBIZ) Earnings Expected to Grow: What to Know Ahead of Q1 Release (Zacks)
12345
affiliate • advertise • careers • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.